NPI: 1790980977 · SEYMOUR, TN 37865 · Primary Care Clinic/Center · NPI assigned 06/18/2007
Authorized official ROSENDAHL, ANDREW controls 20+ related entities in our dataset. Read more
| Authorized Official | ROSENDAHL, ANDREW (CHIEF FINANCIAL OFFICER) |
| Parent Organization | EAST TENNESSEE CHILDREN'S HOSPITAL PRIMARY CARE CENTER INC. |
| NPI Enumeration Date | 06/18/2007 |
Other providers sharing the same authorized official: ROSENDAHL, ANDREW
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 272 | $10K |
| 2019 | 400 | $14K |
| 2020 | 657 | $31K |
| 2021 | 2,143 | $93K |
| 2022 | 2,794 | $123K |
| 2023 | 2,912 | $127K |
| 2024 | 2,970 | $124K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4,536 | 3,660 | $332K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1,091 | 980 | $51K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 287 | 246 | $29K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 195 | 183 | $24K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1,493 | 1,182 | $16K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 332 | 305 | $16K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 335 | 299 | $15K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 87 | 79 | $10K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 79 | 65 | $8K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 378 | 333 | $7K |
| 92551 | 383 | 340 | $5K | |
| 99177 | 884 | 787 | $4K | |
| 96127 | 428 | 278 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 28 | 24 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 141 | 101 | $460.17 |
| 3008F | 883 | 784 | $331.55 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 65 | 60 | $140.76 |
| 90686 | 140 | 135 | $110.92 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 15 | 13 | $97.76 |
| 96161 | 14 | 12 | $62.44 | |
| 94760 | 14 | 12 | $23.26 | |
| 90670 | 32 | 27 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 65 | 60 | $0.00 |
| 90661 | 12 | 12 | $0.00 | |
| 36416 | 231 | 174 | $0.00 |